Results 131 to 140 of about 11,004,439 (292)

Outcome Assessment in Children and Adolescents With Chronic Pain: An International Clinical Practice Survey. [PDF]

Eur J Pain
Miró J, Sánchez-Rodríguez E, Jensen MP, Liossi C, Lord SM, Gobina I, Skidmore N, O'Keeffe M, Walker SM, de la Vega R, Ingelmo P, Koechlin H, Ståhl M, Stinson J, Wicksell RK, Finley GA, Cebrecos J, Goubert L, Reinoso-Barbero F, Rosenberger DC, Pogatzki-Zahn EM.   +20 more
europepmc   +1 more source

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham, Jasibel Vasquez‐Gonzalez, Samantha M. Barnada, Salome Tchotorlishvili, Latese Jones, Ryan Maguire, Genevieve Lewis, Kinza Rizwan, Jenny Deng, Salma Koachar, Drithi Patel, Hailey Shankle, Tessa Mulders, Namra Ajmal, Charalambos Solomides, Emad S. Alnemri, Teresa F. Alnemri, Ayesha A. Shafi, Leonard G. Gomella, Wm Kevin Kelly, Steven B. McMahon, Matthew J. Schiewer   +21 more
wiley   +1 more source

Outcome Assessment of Femoral Shaft Fractures Managed by Nailing and Derotation Plating. [PDF]

J Orthop Case Rep
Pandor I, Sharma A, Shahzad A, Ali F, Shaikh A, Jagdale A.   +5 more
europepmc   +1 more source

Clinical outcome assessment in malignant glioma trials: measuring signs, symptoms, and functional limitations.

Neuro-Oncology, 2016
J. Blakeley, S. Coons, J. Corboy, N. Kline Leidy, T. Mendoza, J. Wefel   +5 more
semanticscholar   +1 more source

Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow‐up biomarkers for breast cancer

Molecular Oncology, EarlyView.
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan, Irina Primac, Emre Etlioglu, Laurens Debruyne, Ann Janssen, Magy Sallam, Kevin Tabury, Roel Quintens, Wiebren Tjalma, Mohammed Abderrafi Benotmane   +9 more
wiley   +1 more source

Molecular characterization of cell decay in inflammation and topological assignment of released cfDNA for integrative laboratory and radiological outcome assessment. [PDF]

Front Cell Infect Microbiol
Gerhards C, Nittka S, Ast V, Evliyaoglu O, Hedtke M, Hench J, Gerigk M, Krebs J, Teufel A, Froelich MF, Fischer A, Schoenberg SO, Neumaier M, Hertel A.   +13 more
europepmc   +1 more source

Comparison of central adjudication of outcomes and onsite outcome assessment on treatment effect estimates.

Cochrane Database of Systematic Reviews, 2016
Lee Aymar Ndounga Diakou, Ludovic Trinquart, A. Hrõbjartsson, C. Barnes, A. Yavchitz, Philippe Ravaud, Isabelle Boutron   +6 more
semanticscholar   +1 more source

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

Molecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts, Senada Koljenović, Elise Daems, Karolien De Wael, Marc Peeters, Léon C. van Kempen, Greetje Vanhoutte, Karen Zwaenepoel, Timon Vandamme   +8 more
wiley   +1 more source

Surgical Procedures for Planting and Revascularization in Catastrophic Hand Injuries and Preliminary Outcome Assessment: Experience of a Regional Care Center. [PDF]

Cureus
González-Vargas IZ, Regil-Juárez C, Salas-Treviño D, González-Cantú CM, Castro-Govea Y.   +4 more
europepmc   +1 more source

Adenosine‐to‐inosine editing of miR‐200b‐3p is associated with the progression of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira, Anna Skwarska, Karolina Chwialkowska, Agnieszka Ostrowska, Gabriela Sokolowska, Anna Zeller, Anna Erol, Andrzej Eljaszewicz, Bartosz Hanczaruk, Anna Michalska‐Falkowska, Agnieszka Tarasik, Joanna Reszec‐Gielazyn, Pawel Knapp, Marcin Moniuszko, Adam Kretowski   +14 more
wiley   +1 more source